Use of Cysteine As a Spectroscopic Probe for Determination of Heme-Scavenging Capacity of Serum Proteins and Whole Human Serum
Total Page:16
File Type:pdf, Size:1020Kb
Use of cysteine as a spectroscopic probe for determination of heme-scavenging capacity of serum proteins and whole human serum Remi Noe, Nina Bozinovic, Maxime Lecerf, Sébastien Lacroix-Desmazes, Jordan Dimitrov To cite this version: Remi Noe, Nina Bozinovic, Maxime Lecerf, Sébastien Lacroix-Desmazes, Jordan Dimitrov. Use of cysteine as a spectroscopic probe for determination of heme-scavenging capacity of serum proteins and whole human serum. Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2019, 172, pp.311-319. 10.1016/j.jpba.2019.05.013. hal-02127294 HAL Id: hal-02127294 https://hal.archives-ouvertes.fr/hal-02127294 Submitted on 13 May 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Journal of Pharmaceutical and Biomedical Analysis 172 (2019) 311–319 Contents lists available at ScienceDirect Journal of Pharmaceutical and Biomedical Analysis j ournal homepage: www.elsevier.com/locate/jpba Use of cysteine as a spectroscopic probe for determination of heme-scavenging capacity of serum proteins and whole human serum 1 1 Rémi Noé , Nina Bozinovic , Maxime Lecerf, Sébastien Lacroix-Desmazes, ∗ Jordan D. Dimitrov Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, F-75006 Paris, France a r t i c l e i n f o a b s t r a c t Article history: Heme serves as a prosthetic group of numerous proteins involved in the oxidative metabolism. As result of Received 19 December 2018 various pathological conditions associated with hemolysis or tissue damage, large quantities of hemopro- Received in revised form 3 May 2019 teins and heme can be released extracellularly. Extracellular heme has pronounced pathogenic effects Accepted 5 May 2019 in hemolytic diseases, mediated by its pro-oxidative and pro-inflammatory activities. The pathogenic Available online 7 May 2019 potential of heme is mostly expressed when the molecule is in protein unbound form. The pathological relevance of free heme deems it necessary to develop reliable approaches for its assessment. Here we Keywords: developed a technique based on UV–vis absorbance spectroscopy, where cysteine was used as a spec- Heme Hemolysis troscopy probe to distinguish between heme-bound to plasma proteins or hemoglobin from free heme. This technique allowed estimation of the heme-binding capacity of human serum, of particular heme Heme-binding proteins Human serum scavenging proteins (albumin, hemopexin) or of immunoglobulins. The main advantage of the proposed Absorbance spectroscopy approach is that it can distinguish free heme from heme associated with proteins with a wide range of affinities. The described strategy can be used for evaluation of heme-binding capacity of human plasma or serum following intravascular hemolysis or for estimation of stoichiometry of interaction of heme with a given protein. © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1. Introduction hemoglobin. As a result of its oxidative potential and prominent hydrophobicity, free heme is inherently toxic molecule. Likewise, Heme (Fe-protoporphyrin IX) is a macrocyclic compound heme is considered as endogenous danger signal (alarmin) that that serves as a prosthetic group of many proteins involved activates different types of immune cells and endothelia, increases in the aerobic metabolism. By transiently interacting with a vascular permeability, triggers complement cascade activation and number of intracellular or membrane-associated proteins, heme dysregulates coagulation [3,4]. Accordingly, extracellular hemo- also participates in the cell signalling and regulation of cellu- proteins and heme contribute to the pathogenesis of diseases such lar functions [1]. Under physiological conditions most of heme is as malaria, sickle cell disease, sepsis, rhabdomyolysis and other. intracellularly sequestered. However, release of large quantities In the clinical practice the assessment of hemolysis is performed of heme-containing proteins (hemoproteins), such as hemoglobin by measurement of the plasma scavenger of hemoglobin, i.e. hap- and myoglobin can occur as consequence of diverse patholo- toglobin [5]. Thus, a decrease in the plasma concentration of this gies. Thus, damage of erythrocytes due to genetic abnormalities protein signifies recent hemolytic events. Extensive hemolysis may of hemoglobin, infections, trauma, or autoimmunity can result also result in overwhelming of scavenging capacity of hemopexin, in intravascular hemolysis and liberation of massive quantities the plasma protein that binds heme with high affinity [6]. In this of extracellular hemoglobin [2]. In extracellular compartment case, the extracellular heme can associate with lower affinity to and upon oxidation, heme relatively easily dissociates from other plasma constituents, including albumin, and lipoproteins [6,7]. However, as albumin has a slow exchange rate (half-life of ca. 20 days), recurrent and extensive hemolysis may also result in ∗ saturation of the heme-binding capacity of this abundant plasma Corresponding author at: INSERM UMRS 1138, Centre de Recherche des Corde- protein. Since the pathologically-relevant form of heme is the one liers, 75006 Paris, France. that is loosely bound to proteins (referred to as free heme), its esti- E-mail addresses: [email protected], [email protected] (J.D. Dimitrov). mation is of utmost clinical importance [3]. However, to the best 1 These authors contributed equally to the work. https://doi.org/10.1016/j.jpba.2019.05.013 0731-7085/© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4. 0/). 312 R. Noé et al. / Journal of Pharmaceutical and Biomedical Analysis 172 (2019) 311–319 of knowledge, there is no estimation of the total heme-scavenging was used directly. After recording the spectra of the protein solu- capacity of human serum. There are commercialized techniques for tions, potassium cyanide, glutathione or cysteine were added to measurement of concentration of total heme in plasma that have the protein solutions at final concentration of 10 mM. Following, been applied in different studies [8–10]. These approaches relay on vigorous homogenization, the spectra were measured as described colorimetric detection of heme or on the pseudo-peroxidase activ- above. ity of heme in the presence of hydrogen peroxide. Nonetheless, these techniques fail to differentiate the hemoprotein-bound from 2.2.3. Determination of cysteine concentration for heme-cysteine free heme. spectral measurements Here we describe a simple method that relays on characteris- Cysteine was diluted in PBS to concentrations of 0.156, 0.312, tic spectral changes of protein-free heme upon interaction with a 0.625, 1.25, 2.5, 5, 10 and 20 mM. The UV–vis spectra of each thiol-containing compound (cysteine). We demonstrated that this concentration of cysteine in the presence of 20 M hemin were technique could be reliably used for estimation of the free extra- measured as described above. To obtain differential spectra, the cellular heme. The method can also be applied for evaluation of the absorbance spectrum in the range 300–700 nm of hemin at 20 M heme-binding capacity of different proteins and human serum as was subtracted from the spectra of hemin in the presence of each well as for assessment of quality of heme-binding proteins used in concentration of cysteine. therapy or as blood substituents. 2.2.4. Building of a calibration curve for heme-cysteine Hemin was diluted in PBS to concentrations of 0.312, 0.625, 1.25, 2. Material and methods 2.5, 5, 10, 20, and 40 M. The UV–vis spectra of each concentration in the presence of excess of cysteine (10 mM final concentration) 2.1. Materials were measured as described above. To obtain differential spec- tra, the absorbance in the range 300–700 nm of heme at a given Hemin was obtained from Frontier Scientific, Inc. (Logan, UT). concentration was subtracted from the spectrum of hemin in the Cysteine, reduced glutathione, potassium cyanide, DMSO, phenyl- presence of cysteine. The obtained differential spectra have promi- hydrazine hydrochloride, 5,5 -dithiobis(2-nitrobenzoic acid), 2,2 - nent absorbance maximum at 364 nm. The values of the differential azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS), human absorbance at this maximum were plotted versus the concentration hemopexin and human hemoglobin were obtained from Sigma- of hemin. Aldrich (St. Louis, MO). All chemicals were with the highest available purity. Human serum albumin (LFB, Les Ulis, France) and 2.2.5. Evaluation of heme-binding capacity of human plasma human pooled immunoglobulin G (IVIg, Endobulin, Baxter USA) proteins were thoroughly dialyzed against PBS and stored before use at − ◦ Human serum albumin, and human pooled IgG were diluted in 20 C at concentrations of 200 mg/ml and 80 mg/ml, respectively. PBS at concentrations ranging from 1.25–320 M (dilution by fac- Human AB serum obtained from healthy donor was purchased from tor of 2). Alternatively, human hemopexin and human monoclonal Etablissement franc¸ ais du sang, Paris, France, (ethical authorization ◦ IgG1 (identified in our previous studies to interact with heme) were N 12/EFS/079). All stock solutions were freshly prepared and used diluted in PBS in concentrations ranging 0.312–40 M. Next, 20 within 24 h. Hemin was dissolved in DMSO to final concentration M final concentration of hemin was added to each protein dilu- of 2 mM. The stock solutions of the other chemicals and proteins tion and UV–vis spectra were recorded as described above.